Literature DB >> 21172654

Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.

Maria Soledad Sosa1, Cynthia Lopez-Haber, Chengfeng Yang, Hongbin Wang, Mark A Lemmon, John M Busillo, Jiansong Luo, Jeffrey L Benovic, Andres Klein-Szanto, Hiroshi Yagi, J Silvio Gutkind, Ramon E Parsons, Marcelo G Kazanietz.   

Abstract

While the small GTPase Rac1 and its effectors are well-established mediators of mitogenic and motile signaling by tyrosine kinase receptors and have been implicated in breast tumorigenesis, little is known regarding the exchange factors (Rac-GEFs) that mediate ErbB receptor responses. Here, we identify the PIP(3)-Gβγ-dependent Rac-GEF P-Rex1 as an essential mediator of Rac1 activation, motility, cell growth, and tumorigenesis driven by ErbB receptors in breast cancer cells. Notably, activation of P-Rex1 in breast cancer cells requires the convergence of inputs from ErbB receptors and a Gβγ- and PI3Kγ-dependent pathway. Moreover, we identified the GPCR CXCR4 as a crucial mediator of P-Rex1/Rac1 activation in response to ErbB ligands. P-Rex1 is highly overexpressed in human breast cancers and their derived cell lines, particularly those with high ErbB2 and ER expression. In addition to the prognostic and therapeutic implications, our findings reveal an ErbB effector pathway that is crucial for breast cancer progression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172654      PMCID: PMC3038344          DOI: 10.1016/j.molcel.2010.11.029

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  53 in total

1.  P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac.

Authors:  Heidi C E Welch; W John Coadwell; Christian D Ellson; G John Ferguson; Simon R Andrews; Hediye Erdjument-Bromage; Paul Tempst; Phillip T Hawkins; Len R Stephens
Journal:  Cell       Date:  2002-03-22       Impact factor: 41.582

2.  Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting.

Authors:  A Marchese; J L Benovic
Journal:  J Biol Chem       Date:  2001-12-07       Impact factor: 5.157

3.  Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.

Authors:  S L Moulder; F M Yakes; S K Muthuswamy; R Bianco; J F Simpson; C L Arteaga
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility.

Authors:  J P Hobson; H M Rosenfeldt; L S Barak; A Olivera; S Poulton; M G Caron; S Milstien; S Spiegel
Journal:  Science       Date:  2001-03-02       Impact factor: 47.728

5.  Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway.

Authors:  R J Lee; C Albanese; M Fu; M D'Amico; B Lin; G Watanabe; G K Haines; P M Siegel; M C Hung; Y Yarden; J M Horowitz; W J Muller; R G Pestell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 6.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

Review 7.  The deaf and the dumb: the biology of ErbB-2 and ErbB-3.

Authors:  Ami Citri; Kochupurakkal Bose Skaria; Yosef Yarden
Journal:  Exp Cell Res       Date:  2003-03-10       Impact factor: 3.905

8.  Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.

Authors:  Ella Atlas; Marina Cardillo; Inderjit Mehmi; Hengameh Zahedkargaran; Careen Tang; Ruth Lupu
Journal:  Mol Cancer Res       Date:  2003-01       Impact factor: 5.852

9.  EGFR-induced cell migration is mediated predominantly by the JAK-STAT pathway in primary esophageal keratinocytes.

Authors:  Claudia D Andl; Takaaki Mizushima; Kenji Oyama; Mark Bowser; Hiroshi Nakagawa; Anil K Rustgi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07-29       Impact factor: 4.052

10.  Reduced expression of PTEN correlates with breast cancer progression.

Authors:  Shikha Bose; Allison Crane; Hanina Hibshoosh; Mahesh Mansukhani; Lynn Sandweis; Ramon Parsons
Journal:  Hum Pathol       Date:  2002-04       Impact factor: 3.466

View more
  108 in total

1.  Epigenetic regulation of phosphatidylinositol 3,4,5-triphosphate-dependent Rac exchanger 1 gene expression in prostate cancer cells.

Authors:  Chuu-Yun A Wong; Hada Wuriyanghan; Yan Xie; Ming-Fong Lin; Peter W Abel; Yaping Tu
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells.

Authors:  Hiroshi Yagi; Wenfu Tan; Patricia Dillenburg-Pilla; Sylvain Armando; Panomwat Amornphimoltham; May Simaan; Roberto Weigert; Alfredo A Molinolo; Michel Bouvier; J Silvio Gutkind
Journal:  Sci Signal       Date:  2011-09-20       Impact factor: 8.192

3.  Timing is everything: Rac1 controls Net1A localization to regulate cell adhesion.

Authors:  Heather S Carr; Jeffrey A Frost
Journal:  Cell Adh Migr       Date:  2013-06-10       Impact factor: 3.405

4.  PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling.

Authors:  Heng-Jia Liu; Lisa M Ooms; Nuthasuda Srijakotre; Joey Man; Jessica Vieusseux; JoAnne E Waters; Yue Feng; Charles G Bailey; John E J Rasko; John T Price; Christina A Mitchell
Journal:  J Biol Chem       Date:  2016-06-29       Impact factor: 5.157

Review 5.  Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.

Authors:  Victoria Wu; Huwate Yeerna; Nijiro Nohata; Joshua Chiou; Olivier Harismendy; Francesco Raimondi; Asuka Inoue; Robert B Russell; Pablo Tamayo; J Silvio Gutkind
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

6.  The first DEP domain of the RhoGEF P-Rex1 autoinhibits activity and contributes to membrane binding.

Authors:  Sandeep K Ravala; Jesse B Hopkins; Caroline B Plescia; Samantha R Allgood; Madison A Kane; Jennifer N Cash; Robert V Stahelin; John J G Tesmer
Journal:  J Biol Chem       Date:  2020-07-13       Impact factor: 5.157

7.  Rac1 is a potential target to circumvent radioresistance.

Authors:  Wen-Ling Wang; Wei-Chien Huang
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

8.  PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1.

Authors:  Hiromichi Ebi; Carlotta Costa; Anthony C Faber; Madhuri Nishtala; Hiroshi Kotani; Dejan Juric; Patricia Della Pelle; Youngchul Song; Seiji Yano; Mari Mino-Kenudson; Cyril H Benes; Jeffrey A Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-10       Impact factor: 11.205

9.  Threonine 680 phosphorylation of FLJ00018/PLEKHG2, a Rho family-specific guanine nucleotide exchange factor, by epidermal growth factor receptor signaling regulates cell morphology of Neuro-2a cells.

Authors:  Katsuya Sato; Tsuyoshi Sugiyama; Takahiro Nagase; Yukio Kitade; Hiroshi Ueda
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

10.  Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.

Authors:  Pedro Rosmaninho; Susanne Mükusch; Valerio Piscopo; Vera Teixeira; Alexandre Asf Raposo; Rolf Warta; Romina Bennewitz; Yeman Tang; Christel Herold-Mende; Stefano Stifani; Stefan Momma; Diogo S Castro
Journal:  EMBO J       Date:  2018-06-14       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.